Clinical Trial

Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors

Study acronym: DUKE PREVENT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic Prevention Clinic for multidisciplinary care. The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, and reduces hospital visits and other healthcare use. Participants will be randomly assigned to one of the two groups. Those referred to the clinic will: 1) Meet with a cardiologist for an initial evaluation. 2) Be referred to other specialists (such as endocrinology, nephrology, or hepatology) based on their needs. 3) Receive ongoing, coordinated care from a team of specialists working together to improve their heart and metabolic health.
Protocol Amendment History 1 change
minor Completion pushed: 2027-12-27 -> 2028-01-27 2026-08-07
Trial Details
NCT Number NCT07117695
Lead Sponsor Duke University
Collaborators: Barnhill Family Foundation
Conditions ASCVD, Hyperlipidemia, Hypertension
Enrollment 150 participants
Start Date 2026-09-02
Primary Completion 2027-09-27 (estimated)
Study Completion 2028-01-27 (estimated)
Updated on ClinicalTrials.gov 2026-08-06